Back to funds
View filing
BROADWOOD CAPITAL INC
hedge fundUpdated 27 days agoManaged by Broadwood Capital Inc • Latest filing Q2 2026
Portfolio value
$1.9B
Q2 2026
Filings
14
Quarterly 13F history
Top-10 concentration
100.0%
Weight of largest holdings
Annualized return
9.6%
Implied from 13F holdings
Portfolio value history
13F-disclosed portfolio value over 14 quarters
Show data table
| Period | Portfolio value |
|---|---|
| Q1 2023 | $1.4B |
| Q2 2023 | $1.3B |
| Q3 2023 | $1.1B |
| Q4 2023 | $1.2B |
| Q1 2024 | $1.3B |
| Q2 2024 | $1.3B |
| Q3 2024 | $1.3B |
| Q4 2024 | $1.3B |
| Q1 2025 | $1.2B |
| Q2 2025 | $1.6B |
| Q3 2025 | $1.7B |
| Q4 2025 | $1.7B |
| Q1 2026 | $1.4B |
| Q2 2026 | $1.9B |
Top holdings
6 positions as of Q2 2026
| # | Stock | Value | Shares | % Portfolio | Change |
|---|---|---|---|---|---|
| 1 | M MNST MONSTER BEVERAGE CORP NEW | $779.3M | 8.11M | 40.73% | Unchanged |
| 2 | S STAA STAAR SURGICAL CO | $462.6M | 16.12M | 24.18% | Unchanged |
| 3 | A AXON AXON ENTERPRISE INC | $388.8M | 693.5K | 20.32% | Unchanged |
| 4 | E ETHA ISHARES TR | $142.7M | 474.9K | 7.46% | Unchanged |
| 5 | I IMDX INSIGHT MOLECULAR DIA INC | $74.8M | 12.68M | 3.91% | Added(+6.3%) |
| 6 | L LCTX LINEAGE CELL THERAPEUTICS IN | $64.9M | 49.56M | 3.39% | Unchanged |